Related Experiment Videos
Hyperstable U1snRNA complementary to the K-ras transcripts induces cell death in pancreatic cancer cells
1Investigative Treatment Division, National Cancer Center Research Institute East, 6-5-1, Kashiwanoha, Kashiwa, Chiba 277-8577, Japan.
Abstract:
One of the critical steps that governs the inhibitory effect of antisense RNA on target gene expression is the association of the antisense RNA with the target RNA molecules. However, until now, no systematic method has been available to select the suitable parts of a gene as antisense targets. In this study, we utilised U1 small nuclear RNA (snRNA) that binds physiologically to the 5' splice site (5'ss) of pre-mRNA, to develop a novel vector system that permits imposed binding of antisense RNA to its target. The 5' free end of U1snRNA was replaced with the antisense sequence against the K-ras gene to generate a hyperstable U1snRNA, whose binding stability to 5'ss of the K-ras transcript is ten-fold higher than that of wild-type U1snRNA. The efficacy of such hyperstable U1snRNA was examined by transducing the expression plasmids into human pancreatic cancer cell lines. This revealed that two of the hyperstable U1snRNAs induced cell death after gene transduction, and significantly reduced the number of G418-resistant colonies to less than 10% of the controls. Furthermore, hyperstable U1snRNA suppressed intraperitoneal dissemination of pancreatic cancer cells in vivo. Hyperstable U1snRNA might be a novel approach to express effective antisense RNA in target cells.
Insights
Researchers developed a novel antisense RNA strategy using U1 small nuclear RNA (snRNA) targeting K-ras. This hyperstable U1snRNA effectively inhibits pancreatic cancer cell growth and dissemination.
Area of Science:
- Molecular Biology
- Gene Therapy
- Oncology
Background:
- Antisense RNA efficacy depends on target RNA binding.
- Systematic methods for selecting antisense targets are lacking.
- U1 small nuclear RNA (snRNA) physiologically binds pre-mRNA 5' splice sites (5'ss).
Purpose of the Study:
- To develop a novel vector system for imposed antisense RNA binding.
- To create a hyperstable U1snRNA with enhanced binding affinity to target RNA.
- To evaluate the therapeutic potential of hyperstable U1snRNA against K-ras in pancreatic cancer.
Main Methods:
- Engineered U1snRNA by replacing its 5' end with an antisense sequence targeting K-ras.
- Generated hyperstable U1snRNA with a ten-fold higher binding stability to K-ras 5'ss.
- Transduced expression plasmids into human pancreatic cancer cell lines and assessed in vivo efficacy.
Main Results:
- Two hyperstable U1snRNAs induced pancreatic cancer cell death post-transduction.
- Reduced G418-resistant colonies to less than 10% of controls.
- Demonstrated suppression of intraperitoneal pancreatic cancer cell dissemination in vivo.
Conclusions:
- Hyperstable U1snRNA represents a novel approach for effective antisense RNA delivery.
- This strategy shows potential for pancreatic cancer therapy by targeting K-ras.
- Enhanced U1snRNA binding stability improves antisense RNA therapeutic efficacy.